282 related articles for article (PubMed ID: 11235100)
1. Quantification and validation of enzyme immunoassay for urinary aflatoxin B1-N7-guanine adduct for biological monitoring of aflatoxins.
Nayak S; Sashidhar RB; Bhat RV
Analyst; 2001 Feb; 126(2):179-83. PubMed ID: 11235100
[TBL] [Abstract][Full Text] [Related]
2. Quantitation of aflatoxin B1-N7-guanine adduct in urine by enzyme-linked immunosorbent assay coupled with immunoaffinity chromatography.
Vidyasagar T; Vyjayanthi V; Sujatha N; Rao BS; Bhat RV
J AOAC Int; 1997; 80(5):1013-22. PubMed ID: 9325579
[TBL] [Abstract][Full Text] [Related]
3. Determination of aflatoxin B1-DNA adduct in rat liver by enzyme immunoassay.
Vidyasagar T; Sujatha N; Sashidhar RB
Analyst; 1997 Jun; 122(6):609-13. PubMed ID: 9282405
[TBL] [Abstract][Full Text] [Related]
4. Direct synthesis of aflatoxin B1-N7 guanine adduct: a reference standard for biological monitoring of dietary aflatoxin exposure in molecular epidemiological studies.
Vidyasagar T; Sujatha N; Sashidhar RB
Food Addit Contam; 1997 Jul; 14(5):457-67. PubMed ID: 9328530
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and characterization of mercapturic acid (N-acetyl-L-cysteine)-aflatoxin B1 adduct and its quantitation in rat urine by an enzyme immunoassay.
Nayak S; Tanuja P; Sashidhar RB
J AOAC Int; 2009; 92(2):487-95. PubMed ID: 19485208
[TBL] [Abstract][Full Text] [Related]
6. Molecular dosimetry of aflatoxin-N7-guanine in human urine obtained in The Gambia, West Africa.
Groopman JD; Hall AJ; Whittle H; Hudson GJ; Wogan GN; Montesano R; Wild CP
Cancer Epidemiol Biomarkers Prev; 1992; 1(3):221-7. PubMed ID: 1339082
[TBL] [Abstract][Full Text] [Related]
7. Effects of multiple risk factors for hepatocellular carcinoma on formation of aflatoxin B1-DNA adducts.
Yu MW; Lien JP; Liaw YF; Chen CJ
Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):613-9. PubMed ID: 8824363
[TBL] [Abstract][Full Text] [Related]
8. Molecular dosimetry in rat urine of aflatoxin-N7-guanine and other aflatoxin metabolites by multiple monoclonal antibody affinity chromatography and immunoaffinity/high performance liquid chromatography.
Groopman JD; Hasler JA; Trudel LJ; Pikul A; Donahue PR; Wogan GN
Cancer Res; 1992 Jan; 52(2):267-74. PubMed ID: 1728400
[TBL] [Abstract][Full Text] [Related]
9. DNA damage by mycotoxins.
Wang JS; Groopman JD
Mutat Res; 1999 Mar; 424(1-2):167-81. PubMed ID: 10064859
[TBL] [Abstract][Full Text] [Related]
10. Plasma antioxidant vitamins, chronic hepatitis B virus infection and urinary aflatoxin B1-DNA adducts in healthy males.
Yu MW; Chiang YC; Lien JP; Chen CJ
Carcinogenesis; 1997 Jun; 18(6):1189-94. PubMed ID: 9214602
[TBL] [Abstract][Full Text] [Related]
11. Excretion of an aflatoxin-guanine adduct in the urine of aflatoxin B1-treated rats.
Bennett RA; Essigmann JM; Wogan GN
Cancer Res; 1981 Feb; 41(2):650-4. PubMed ID: 6778611
[TBL] [Abstract][Full Text] [Related]
12. Assessment of aflatoxin exposure using serum and urinary biomarkers in São Paulo, Brazil: A pilot study.
Jager AV; Tonin FG; Baptista GZ; Souto PC; Oliveira CA
Int J Hyg Environ Health; 2016 May; 219(3):294-300. PubMed ID: 26740158
[TBL] [Abstract][Full Text] [Related]
13. Molecular epidemiology of aflatoxin exposures: validation of aflatoxin-N7-guanine levels in urine as a biomarker in experimental rat models and humans.
Groopman JD; Wild CP; Hasler J; Junshi C; Wogan GN; Kensler TW
Environ Health Perspect; 1993 Mar; 99():107-13. PubMed ID: 8319607
[TBL] [Abstract][Full Text] [Related]
14. Fecal and urinary excretion of aflatoxin B1 metabolites (AFQ1, AFM1 and AFB-N7-guanine) in young Chinese males.
Mykkänen H; Zhu H; Salminen E; Juvonen RO; Ling W; Ma J; Polychronaki N; Kemiläinen H; Mykkänen O; Salminen S; El-Nezami H
Int J Cancer; 2005 Jul; 115(6):879-84. PubMed ID: 15723309
[TBL] [Abstract][Full Text] [Related]
15. Molecular dosimetry of urinary aflatoxin-N7-guanine and serum aflatoxin-albumin adducts predicts chemoprotection by 1,2-dithiole-3-thione in rats.
Groopman JD; DeMatos P; Egner PA; Love-Hunt A; Kensler TW
Carcinogenesis; 1992 Jan; 13(1):101-6. PubMed ID: 1733561
[TBL] [Abstract][Full Text] [Related]
16. Fluorescence quantification of aflatoxin N7-guanine adducts.
Weaver VM; Groopman JD
Cancer Epidemiol Biomarkers Prev; 1994 Dec; 3(8):669-74. PubMed ID: 7881340
[TBL] [Abstract][Full Text] [Related]
17. Mutational properties of the primary aflatoxin B1-DNA adduct.
Bailey EA; Iyer RS; Stone MP; Harris TM; Essigmann JM
Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1535-9. PubMed ID: 8643667
[TBL] [Abstract][Full Text] [Related]
18. Enzyme immunoassay for aflatoxin B1-lysine adduct and its validation.
Sujatha N; Suryakala S; Rao BS
J AOAC Int; 2001; 84(5):1465-74. PubMed ID: 11601466
[TBL] [Abstract][Full Text] [Related]
19. Modulation of aflatoxin metabolism, aflatoxin-N7-guanine formation, and hepatic tumorigenesis in rats fed ethoxyquin: role of induction of glutathione S-transferases.
Kensler TW; Egner PA; Davidson NE; Roebuck BD; Pikul A; Groopman JD
Cancer Res; 1986 Aug; 46(8):3924-31. PubMed ID: 2873884
[TBL] [Abstract][Full Text] [Related]
20. Molecular dosimetry of urinary aflatoxin-DNA adducts in people living in Guangxi Autonomous Region, People's Republic of China.
Groopman JD; Zhu JQ; Donahue PR; Pikul A; Zhang LS; Chen JS; Wogan GN
Cancer Res; 1992 Jan; 52(1):45-52. PubMed ID: 1727385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
